Owen G. Hosseinzadeh
Associate
Owen G. Hosseinzadeh focuses his practice on regulatory, compliance, and enforcement matters across the spectrum of products regulated by the US Food and Drug Administration (FDA). Owen counsels clients at each stage of the product life cycle, advises clients in connection with transactional matters, and represents clients in adversarial proceedings involving enforcement agencies or disputes between competitors. He often works with companies developing emerging technologies or facing uncertain regulatory and enforcement landscapes, such as those in the fields of digital health, food, and biotechnology.
- A large-cap pharmaceutical company in connection with its acquisition of a biopharmaceutical company regarding clinical trials regulation, in vitro diagnostic regulation, and advertising and promotional issues
- A multinational technology company regarding medical device classification, clinical laboratory regulation, and direct access testing
- A multinational retail company regarding the implementation of a digital food traceability and tracking system
- A technology company regarding corporate practice of medicine laws and the regulatory landscape for its AI-driven health and wellness chatbots
- A specialty pharmaceutical company in connection with adversarial proceedings involving drug compounding regulations
- A multinational beauty and personal care company regarding the implementation of an adverse event reporting system for its cosmetic products
- A software company, one of the largest providers of health information technology services, regarding fraud waste and abuse prevention, interactions with pharmaceutical and medical technology manufacturers, and federal payor compliance
- A genetic testing and molecular diagnostics company in an intellectual property and antitrust dispute
- A physician in criminal proceedings regarding telemedicine and controlled substance regulations
- An investment firm in connection with its purchase of a logistics company regarding the warehousing and transportation of FDA-regulated products
- Harvard Law School, 2022, J.D.
- University of California, Los Angeles, 2017, B.A., Phi Beta Kappa
- District of Columbia
- California
- US Patent and Trademark Office
- US District Court for the Southern District of California
